You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

BARR Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BARR, and what generic and branded alternatives to BARR drugs are available?

BARR has one hundred and seventy-five approved drugs.

There are seven tentative approvals on BARR drugs.

Summary for BARR

US Patents:	0
Tradenames:	122
Ingredients:	96
NDAs:	175

Drugs and US Patents for BARR

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Barr	GALANTAMINE HYDROBROMIDE	galantamine hydrobromide	CAPSULE, EXTENDED RELEASE;ORAL	078189-002	Sep 15, 2008	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Barr Labs Inc	CLOZAPINE	clozapine	TABLET, ORALLY DISINTEGRATING;ORAL	090308-002	Nov 25, 2015	AB	RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Barr	DROSPIRENONE AND ETHINYL ESTRADIOL	drospirenone; ethinyl estradiol	TABLET;ORAL	078515-001	Mar 30, 2009		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Barr	ERYTHROMYCIN ESTOLATE	erythromycin estolate	CAPSULE;ORAL	062162-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.